Type 1 Diabetes Trial, Recruiting NCT07144696 Sponsor: Peking University First Hospital Condition: Type 1 Diabetes
Back to Type 1 Diabetes

Type 1 Diabetes Trial, Recruiting

NCT07144696
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have been diagnosed with type 1 diabetes according to World Health Organization diagnostic criteria
  • People who are able and willing to take part in a 12-hour structured diabetes education course
  • People who are able and willing to attend regular follow-up appointments at a clinic
  • People who are willing to participate voluntarily and sign a consent form

Who may not be able to join:

  • People who have a form of diabetes other than adult-onset type 1 diabetes, including type 2 diabetes or other specific types
  • People with severe diabetes-related complications affecting small blood vessels, such as advanced eye disease (proliferative retinopathy), high levels of protein in the urine, or nerve pain and nerve damage that is difficult to control
  • People who have been hospitalised in the 3 months before joining due to a stroke, heart attack, or serious circulation problems in the legs that required a procedure or amputation
  • People whose blood pressure remains very high (above 180/110 mmHg) and cannot be brought below 160/110 mmHg within one week
  • People with significantly reduced kidney function, severely elevated liver enzymes, or high bilirubin levels lasting more than one week (confirm with trial site for specific values)
  • People who have used certain medications that can affect blood sugar levels for more than one week in the past 12 weeks — such as steroid tablets or infusions, growth hormone, certain hormonal treatments, high-dose water tablets, or antipsychotic medications (some low-dose blood pressure medications and thyroid replacement therapy may be exceptions — confirm with trial site)
  • People with an active widespread infection, a serious accompanying illness, a malignant tumour, or chronic diarrhoea
  • People with severe memory or thinking difficulties, mental illness, or other conditions that may make it hard to complete the study
  • People who are unable or unwilling to attend follow-up visits, or whom the research doctors consider unlikely to be able to complete the study
  • People whom the research doctors consider unsuitable for any other reason, based on the individual's circumstances

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8613811135033

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Peking University First Hospital
Registry
ClinicalTrials.gov
Start date
5 August 2025
Est. completion
1 November 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Glycated hemoglobin

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov